Current Trends and Limitations in Dengue Antiviral Research
Dengue is the most prevalent arthropod-borne viral disease worldwide and affects approximately 2.5 billion people living in over 100 countries. Increasing geographic expansion of <i>Aedes aegypti</i> mosquitoes (which transmit the virus) has made dengue a global health concern. There are...
Main Authors: | Juliet O. Obi, Hernando Gutiérrez-Barbosa, Joel V. Chua, Daniel J. Deredge |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Tropical Medicine and Infectious Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2414-6366/6/4/180 |
Similar Items
-
Potential Therapeutic Agents for Feline Calicivirus Infection
by: Tulio M. Fumian, et al.
Published: (2018-08-01) -
The experience in treatment of dengue fever using antiviral drug riamilovir in the Republic of Guinea (case report)
by: Oleg V. Maltsev, et al.
Published: (2023-02-01) -
Lipophilic Nucleoside Triphosphate Prodrugs of Anti‐HIV Active Nucleoside Analogs as Potential Antiviral Compounds
by: Xiao Jia, et al.
Published: (2023-12-01) -
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
by: Hanadi Sinokrot, et al.
Published: (2017-10-01) -
The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses
by: Daniel Enosi Tuipulotu, et al.
Published: (2019-05-01)